Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma

Astrid Murumägi; Daniela Ungureanu; Suleiman Khan; Mariliina Arjama; Katja Välimäki; Aleksandr Ianevski; Philipp Ianevski; Rebecka Bergstrom; Alice Dini; Anna Kanerva; Riitta Koivisto-Korander; Johanna Tapper; Heini Lassus; Mikko Loukovaara; Andrus Mägi; Akira Hirasawa; Daisuke Aoki; Vilja Pietiäinen; Teijo Pellinen; Ralf Butzow; Tero Aittokallio; Olli Kallioniemi

doi:10.1038/s41416-022-02067-z

Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma

Astrid Murumägi, Daniela Ungureanu, Suleiman Khan, Mariliina Arjama, Katja Välimäki, Aleksandr Ianevski, Philipp Ianevski, Rebecka Bergstrom, Alice Dini, Anna Kanerva, Riitta Koivisto-Korander, Johanna Tapper, Heini Lassus, Mikko Loukovaara, Andrus Mägi, Akira Hirasawa, Daisuke Aoki, Vilja Pietiäinen, Teijo Pellinen, Ralf ButzowTero Aittokallio, Olli Kallioniemi

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	British Journal of Cancer
Vuosikerta	128
Numero	4
Sivut	678–690
Sivumäärä	13
ISSN	0007-0920
DOI - pysyväislinkit	https://doi.org/10.1038/s41416-022-02067-z
Tila	Julkaistu - 16 helmik. 2023
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

Reprogrammed cells
Sensitivity
Resistant
3122 Syöpätaudit

Pääsy asiakirjaan

10.1038/s41416-022-02067-z

s41416-022-02067-zLopullinen julkaistu versio, 3 MBLisenssi: CC BY

Siteeraa tätä

Murumägi, A., Ungureanu, D., Khan, S., Arjama, M., Välimäki, K., Ianevski, A., Ianevski, P., Bergstrom, R., Dini, A., Kanerva, A., Koivisto-Korander, R., Tapper, J., Lassus, H., Loukovaara, M., Mägi, A., Hirasawa, A., Aoki, D., Pietiäinen, V., Pellinen, T., ... Kallioniemi, O. (2023). Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma. British Journal of Cancer, 128(4), 678–690. https://doi.org/10.1038/s41416-022-02067-z

@article{82a46ff476604e799f40fd864405dcb7,

title = "Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma",

keywords = "Reprogrammed cells, Sensitivity, Resistant, 3122 Cancers",

author = "Astrid Murum{\"a}gi and Daniela Ungureanu and Suleiman Khan and Mariliina Arjama and Katja V{\"a}lim{\"a}ki and Aleksandr Ianevski and Philipp Ianevski and Rebecka Bergstrom and Alice Dini and Anna Kanerva and Riitta Koivisto-Korander and Johanna Tapper and Heini Lassus and Mikko Loukovaara and Andrus M{\"a}gi and Akira Hirasawa and Daisuke Aoki and Vilja Pieti{\"a}inen and Teijo Pellinen and Ralf Butzow and Tero Aittokallio and Olli Kallioniemi",

year = "2023",

month = feb,

day = "16",

doi = "10.1038/s41416-022-02067-z",

language = "English",

volume = "128",

pages = "678–690",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "4",

}

Murumägi, A , Ungureanu, D , Khan, S , Arjama, M , Välimäki, K , Ianevski, A, Ianevski, P, Bergstrom, R, Dini, A, Kanerva, A, Koivisto-Korander, R, Tapper, J, Lassus, H, Loukovaara, M, Mägi, A, Hirasawa, A, Aoki, D, Pietiäinen, V , Pellinen, T , Butzow, R , Aittokallio, T & Kallioniemi, O 2023, 'Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma', British Journal of Cancer, Vuosikerta 128, Nro 4, Sivut 678–690. https://doi.org/10.1038/s41416-022-02067-z

Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer : real-time therapy tailoring for a patient with low-grade serous carcinoma. / Murumägi, Astrid ; Ungureanu, Daniela ; Khan, Suleiman et al.

julkaisussa: British Journal of Cancer, Vuosikerta 128, Nro 4, 16.02.2023, s. 678–690.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer

T2 - real-time therapy tailoring for a patient with low-grade serous carcinoma

AU - Murumägi, Astrid

AU - Ungureanu, Daniela

AU - Khan, Suleiman

AU - Arjama, Mariliina

AU - Välimäki, Katja

AU - Ianevski, Aleksandr

AU - Ianevski, Philipp

AU - Bergstrom, Rebecka

AU - Dini, Alice

AU - Kanerva, Anna

AU - Koivisto-Korander, Riitta

AU - Tapper, Johanna

AU - Lassus, Heini

AU - Loukovaara, Mikko

AU - Mägi, Andrus

AU - Hirasawa, Akira

AU - Aoki, Daisuke

AU - Pietiäinen, Vilja

AU - Pellinen, Teijo

AU - Butzow, Ralf

AU - Aittokallio, Tero

AU - Kallioniemi, Olli

PY - 2023/2/16

Y1 - 2023/2/16

KW - Reprogrammed cells

KW - Sensitivity

KW - Resistant

KW - 3122 Cancers

U2 - 10.1038/s41416-022-02067-z

DO - 10.1038/s41416-022-02067-z

M3 - Article

C2 - 36476658

VL - 128

SP - 678

EP - 690

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 4

ER -